“ Pharmacogenetics of Glucocorticoid Replacement Could Optimize the Treatment of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency ”. Clinics, vol. 66, no. 8, Jan. 2011, pp. 1361-6, https://doi.org/10.1590/S1807-59322011000800009.